Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jasper Therapeutics Q2 EPS $(0.29)

Jasper Therapeutics Q2 EPS $(0.29)

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.29) per share.

byMichael Horton

August 12, 2022

1 minute read

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.29) per share.

James Hardie Industries Lowers FY23 Revenue From $650M-$710M To $600M-$620M

By Happy Mohamed

February 14, 1:45 AM

Outlook and Earnings Guidance Based on our lower than expected second half volume results in both North America and APAC and restructuring charges incurred in the second half, management has lowered the fiscal

JHX

What Does AGNC Investment’s Debt Look Like?

By Benzinga Insights

November 21, 1:16 PM

Shares of AGNC Investment's Inc. (NASDAQ:AGNC) moved lower by 26.58% in the past three months. Before having a look at the importance of debt, let's look at how much debt AGNC Investment's has.

AGNC

Earnings

Cal-Maine Foods’s Earnings Outlook

By Benzinga Insights

January 2, 10:00 AM

Cal-Maine Foods (NASDAQ:CALM) is set to give its latest quarterly earnings report on Wednesday, 2024-01-03. Here’s what investors…

CALM

‘Big Short’ Investor Michael Burry Says Nancy Pelosi’s Chip Stock Buy Should Be Illegal

By Shivdeep Dhaliwal

July 20, 11:49 PM

“Big Short” fame investor Michael Burry said U.S. House Of Representatives Speaker Nancy Pelosi “made a bundle” on semiconductor stocks she recently purchased because she knew a key bill would make it through the Senate.

NVDA

Jasper Therapeutics Q2 EPS $(0.29)

Related Posts

James Hardie Industries Lowers FY23 Revenue From $650M-$710M To $600M-$620M

What Does AGNC Investment’s Debt Look Like?

Cal-Maine Foods’s Earnings Outlook

‘Big Short’ Investor Michael Burry Says Nancy Pelosi’s Chip Stock Buy Should Be Illegal